Please ensure Javascript is enabled for purposes of website accessibility
OnCore Login

Return to Trial Database

HCRN-GU07-122

A Pilot Study of Neoadjuvant Dasatinib Followed by Radical Cystectomy for Transitional Cell Carcinoma of the Bladder

Status

Study Completed

Cancer Type(s)

Bladder

Study Contact

Publications

  • B Knudsen, NM Hahn, S Daneshmand, EM Posadas, S Muhanty, SP Lerner, G Sonpavde
A phase II trial of neoadjuvant dasatinib (Neo-D) in muscle-invasive urothelial carcinoma of the bladder (miUCB)
  • N Hahn, S Daneshmand, EM Posadas, MO Koch, R Bihrle, R Foster, TA Masterson, L Cheng, Z Liu, T Breen, MT Fleming, R Lance, CW Ryan, CL Corless, MD Galsky, AS Alva, C Mitchell, SS Shen, SP Lerner, G Sonpavde
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
  • NM Hahn, BS Knudsen, S Daneshmand, MO Koch, R Bihrle, RS Foster, TA Gardner, L Cheng, Z Liu, T Breen, MT Fleming, R Lance, CL Corless, AS Alva, SS Shen, F Huang, A Gertych, GE Gallick, J Mallick, C Ryan, MD Galsky, SP Lerner, EM Posadas, G Sonpavde

Trial Locations

All sites in which the trial HCRN-GU07-122 being conducted in.
No data was found